World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02195102
Date of registration: 11/07/2014
Prospective Registration: Yes
Primary sponsor: Michael Kang-Yin Lee, MD
Public title: The Asian Pacific TAVR Multicenter Registry AP TAVR
Scientific title: Evaluation of Clinical Outcomes of Transcatheter Aortic Valve Replacement in the Asian Population The Asian Pacific TAVI Multicenter Registry A MULTICENTER, OBSERVATIONAL STUDY
Date of first enrolment: December 2014
Target sample size: 2000
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT02195102
Study type:  Observational
Study design:  Observational Model: Cohort  
Phase:  N/A
Countries of recruitment
China Japan Korea, Republic of Malaysia Philippines Singapore Taiwan Thailand
Contacts
Name:     Elly Jeong-youn Bae, Research Nurse
Address: 
Telephone:
Email: cvcrc10@amc.seoul.kr
Affiliation: 
Name:     Edgar L.W. Tay, MD
Address: 
Telephone:
Email:
Affiliation:  National University Heart Center (National University Health System), Singapore
Name:     Seung-jung Park, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Asan Medical Center, Republic of Korea
Name:     Machael Kang-Yin Lee, MD
Address: 
Telephone:
Email:
Affiliation:  Queen Elizabeth Hospital, HongKong
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with symptomatic severe aortic stenosis who are not candidates for surgical
aortic valve replacement because of coexisting illnesses.

- The patient or guardian agrees to the study protocol and the schedule of clinical
follow-up, and provides informed, written consent, as approved by the appropriate
Institutional Review Board/Ethics Committee of the respective clinical site.



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Aortic Valve Stenosis
Intervention(s)
Device: Transcatheter aortic valve Replacement
Primary Outcome(s)
Death from any cause [Time Frame: 5 years]
Death from any cause [Time Frame: 6 months]
Death from any cause [Time Frame: 2 years]
Death from any cause [Time Frame: 1 month]
Death from any cause [Time Frame: 1 year]
Death from any cause [Time Frame: 3 years]
Death from any cause [Time Frame: 4 years]
Secondary Outcome(s)
Acute kidney injury [Time Frame: 5 years]
Acute kidney injury [Time Frame: 6 months]
Bleeding events [Time Frame: 3 years]
Death from cardiac cause [Time Frame: 4 years]
Bleeding events [Time Frame: 5 years]
Death from cardiac cause [Time Frame: 5 years]
Device success [Time Frame: 1 month]
Device success [Time Frame: 1 year]
Myocardial infarction [Time Frame: 6 months]
Repeat hospitalization [Time Frame: 6 months]
Stroke [Time Frame: 1 month]
Stroke [Time Frame: 4 years]
Acute kidney injury [Time Frame: 3 years]
Bleeding events [Time Frame: 4 years]
Death from cardiac cause [Time Frame: 2 years]
Device success [Time Frame: 3 years]
Myocardial infarction [Time Frame: 1 year]
Repeat hospitalization [Time Frame: 3 years]
Death from cardiac cause [Time Frame: 6 months]
Device success [Time Frame: 5 years]
Device success [Time Frame: 6 months]
Myocardial infarction [Time Frame: 1 month]
Acute kidney injury [Time Frame: 4 years]
Bleeding events [Time Frame: 2 years]
Stroke [Time Frame: 3 years]
Acute kidney injury [Time Frame: 1 year]
Bleeding events [Time Frame: 1 year]
Death from cardiac cause [Time Frame: 1 month]
Device success [Time Frame: 4 years]
Vascular complication [Time Frame: 1 year]
Acute kidney injury [Time Frame: 2 years]
Death from cardiac cause [Time Frame: 3 years]
Repeat hospitalization [Time Frame: 4 years]
Stroke [Time Frame: 2 years]
Stroke [Time Frame: 5 years]
Myocardial infarction [Time Frame: 3 years]
Vascular complication [Time Frame: 2 years]
Device success [Time Frame: 2 years]
Repeat hospitalization [Time Frame: 1 year]
Repeat hospitalization [Time Frame: 2 years]
Stroke [Time Frame: 1 year]
Vascular complication [Time Frame: 6 months]
Myocardial infarction [Time Frame: 4 years]
Vascular complication [Time Frame: 1 month]
Vascular complication [Time Frame: 3 years]
Vascular complication [Time Frame: 4 years]
Vascular complication [Time Frame: 5 years]
Acute kidney injury [Time Frame: 1 month]
Bleeding events [Time Frame: 1 month]
Bleeding events [Time Frame: 6 months]
Death from cardiac cause [Time Frame: 1 year]
Myocardial infarction [Time Frame: 2 years]
Myocardial infarction [Time Frame: 5 years]
Repeat hospitalization [Time Frame: 1 month]
Repeat hospitalization [Time Frame: 5 years]
Stroke [Time Frame: 6 months]
Secondary ID(s)
AMCCV 2013-12
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Asan Medical Center
Cardiovascular Clinical Research
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history